The Most Favoured Nation (MFN) drug pricing policy proposed in the United States is not expected to have an immediate impact on Indian pharmaceutical companies, according to industry analysts and market experts. The policy seeks to align US prescr...
Cipla partners with Pfizer to exclusively market five established brands in India, strengthening acute therapy presence and expanding patient access through a nationwide distribution network.
AstraZeneca Pharma India Ltd. (AZPIL) has received approval from the Central Drugs Standard Control Organisation (CDSCO) to import, sell, and distribute datopotamab deruxtecan (Dato-DXd) in India for the treatment of metastatic breast cance...
Senores Pharmaceuticals acquires Apnar Pharma in a move that strengthens its footprint across regulated global markets. The company has signed a definitive agreement to acquire a 100 percent equity stake in Apnar Pharma Private Limited, along...
Takeda’s experimental AI-crafted psoriasis pill, zasocitinib, achieved impressive results in two pivotal Phase?3 trials, marking a major milestone in the treatment of plaque psoriasis.Compared to placebo and active comparators, the once-per-day...
Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for travoprost ophthalmic solution USP, 0.004%. The product is indicated for the reductio...
Novartis is also rapidly increasing its business footprint in India making India its biggest global R&D center outside Switzerland. The Swiss firm has a workforce exceeding 9,000 employees in Hyderabad and Mumbai. This is a significant change...
.png "Lupin Achieves Key CHMP Milestone for Ranibizumab Biosimilar")
Lupin Limited, a global pharma company, announced today that the Committee for Medicinal Products to Human Use (CHMP) of the European Medicines Agency had given a positive opinion. The opinion suggests that Lupin marketing authorization be...
Bristol Myers Squibb has launched Mosaic AI content hub, a first-of-its-kind, AI-powered platform designed to reshape how pharmaceutical content is created and delivered. Developed with Accenture, the new hub marks a major step forward in...
The summit commenced with a welcome address by Rajesh Khubchandani, Co-Founder & Managing Director, Team Marksmen Network, who emphasized, “As we start this journey, we have seen a lot of narratives and stories being told. The way a select few organi
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")